Bio/Pharmaceutical Outsourcing Report, March 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $995	31 Pages	GlobalData	April, 2025	GBDT19993154

Best Price Guarantee
Price	from $995
Length	31 Pages
Publisher	GlobalData
Published Date	April, 2025
SKU	GBDT19993154

Bio/Pharmaceutical Outsourcing Report, March 2025

Summary

The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.

Scope

This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from GlobalData's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for -

– CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.– Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.– Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.Reasons to Buy

Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
Learn about the past quarter’s M&A and financing deals in the manufacturing space.
Identify the latest contract service agreements.
Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
Stay ahead of disruption with updates on supply chain obstacles and new regulations.

1 Industry Trends: 1.1 US healthcare agency cuts: impacts on drug approvals and supply chain; 1.2 WuXi AppTec sells UK-US units, but annual results show foreign contracts continue despite China tensions; 1.3 Trump tariffs drive pharma manufacturing to US but risk inflation and disruption; 1.4 Semaglutide shortage ends as FDA sets deadline for compounders; 1.5 Mandatory drug stock monitoring empowers EU to tackle shortages; 1.6 Is space really the next frontier for medical manufacturing?; 1.7 Regulatory trends in brief
2 Industry Analysis: 2.1 Contract service agreements; 2.2 Contract manufacturing – opportunities and threats; 2.3 Quarterly mergers, acquisitions, and financing – Q1 2025
3 Value Chain: 3.1 Compounding; 3.2 API biologics – protein and peptide; 3.3 API biologics – cell, gene, vaccine, and virus; 3.4 Commercial dose manufacturing and packaging; 3.5 Clinical dose manufacturing and packaging; 3.6 Analytical services
4 About GlobalData
5 About the Authors
6 Contact Us
List of Tables: Table 1: Contract service agreements; Table 2: Contract manufacturing: opportunities and threats – potentially positive; Table 3: Contract manufacturing: opportunities and threats – potentially negative; Table 4: Mergers, acquisitions, and financing – Q1 2025